| ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 171
C Conference Agenda
Conference on Resuscitation Fluid Design and Resuscitation Protocols for Combat Casualties
National Academy of Sciences Auditorium
2101 Constitution Avenue, N.W.
Washington, D.C.
Thursday, September 17, 1998
8:30 a.m.
WELCOMING REMARKS AND OVERVIEW OF THE CONFERENCE
Clyde J. Behney
Deputy Executive Officer
Institute of Medicine
Anna Johnson-Winegar, Ph.D.
Head, Human Systems Department
Office of Naval Research
David E. Longnecker, M.D.
Robert D. Dripps Professor and Chair
Department of Anesthesia
University of Pennsylvania Health System
Committee Chair
OCR for page 172
9:00
PANEL 1: OVERVIEW OF FLUID RESUSCITATION
(15-minute presentations, each followed by 5 minutes of discussion)
Ronald F. Bellamy, M.D., Colonel, USA, Retired
Borden Institute, Walter Reed Army Institute of Research
Trauma Epidemiology of Combat Casualties
Howard Champion, M.D.
University of Maryland, Baltimore
Classical Shock Research vs. Resuscitation Needs
Uwe Kreimeier, M.D.
Department of Anesthesiology, University of Munich
Resuscitation Research in Europe
10:00
BREAK
10:20
PANEL 2: TREATMENT OF BATTLEFIELD TRAUMA
(15-minute presentations, each followed by 5 minutes of discussion)
Issues
Steven P. Bruttig, Ph.D.
Novel Technologies, Inc.
Issues in Trauma Treatment on the Battlefield
Frank Butler, Jr., M.D., Captain, USN
Naval Special Warfare Command Detachment Pensacola
Issues of Trauma Treatment for Special Forces
Geoffrey S. F. Ling, M.D., Ph.D.
Uniformed Services University of the Health Sciences
Neurological Aspects of Battlefield Trauma
Strategies
Michael M. Krausz, M.D.
RAMBAM Medical Center, Haifa, Israel
Resuscitation Strategies in the Israeli Army
George C. Kramer, Ph.D.
University of Texas, Galveston
Hypertonic Saline/Dextran Resuscitation: Novel Methods of Delivering Fluids on the Battlefield
OCR for page 173
Monitoring
Frederick J. Pearce, Ph.D.
Walter Reed Army Institute of Research
Casualty Resuscitation and Monitoring Devices Under Development by the U.S. Army
12:20 p.m.
LUNCH
1:20
AGENDA ACCOMODATION I
(15-minute presentations, each followed by 5 minutes of discussion)
Jane Shelby, Ph.D.
University of Utah
Melatonin Therapy in Acute Trauma (from Panel 7)
Richard McCarron, M.D.
Naval Medical Research Institute
Hibernation as a Model for Tolerance to Ischemia (from Panel 8)
2:00
PANEL 3: ANIMAL MODELS OF HEMORHAGIC SHOCK
(15-minute presentations, each followed by 5 minutes of discussion)
Frederick J. Pearce, Ph.D.
Walter Reed Army Institute of Research
Animal Models of Hemorrhagic Shock and Physiological Responses to Hemorrhage
Kenneth G. Proctor, Ph.D.
University of Tennessee
Models of Combined Hemorrhage and Injury
Alfred Ayala, Ph.D.
Rhode Island Hospital
Effects of the Extent of Hypotension and Rates of Hemorrhage and Outcome in Animal Models
3:00
BREAK
3:20
PANEL 4: PATHOPHYSIOLOGY AND METABOLIC SEQUELAE
(15-minute presentations, each followed by 5 minutes of discussion)
OCR for page 174
Richard Veech, M.D., D.Phil.
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
Cellular Energetics and Fluid Design Issues
Ajay Verma, M.D., Ph.D., Major, USA
Uniformed Services University of the Health Sciences
Strategies for Supporting Energy Demand During Resuscitation
Edwin A. Deitch, M.D.
New Jersey Medical School
Sequelae of Hemorrhagic Shock (Intestinal Ischemia, Bacterial Translocation, ARDS)
Irshad H. Chaudry, Ph.D.
Rhode Island Hospital
Immune and Endocrine Aspects of Hemorrhage
Patricia E. Molina, M.D., Ph.D.
North Shore University Hospital
Cytokines in Hemorrhagic Shock
Timothy R. Billiar, M.D.
University of Pittsburgh
Role of Induced Nitric Oxide Synthase in Hemorrhagic Shock
5:20
CLOSING REMARKS
David E. Longnecker, M.D.
Committee Chair
5:45
ADJOURN
OCR for page 175
National Academy of Sciences Auditorium
2101 Constitution Avenue, N.W.
Washington, D.C.
Friday, September 18, 1998
8:15 a.m.
OPENING REMARKS
David E. Longnecker, M.D.
Committee Chair
8:25
PANEL 5: COMPLICATIONS OF RESUSCITATION
(15-minute presentations, each followed by 5 minutes of discussion)
Richard Veech, M.D., D.Phil.
National Institutes of Health
(for Kieran Clarke, Ph.D., Oxford University)
Acute Toxicity of Lactate
C. Robert Valeri, M.D.
Boston University
Red Blood Cells and Platelets in Hemostasis
Peter Rhee, M.D.
Uniformed Services University of the Health Sciences
Stimulation of Inflammation by Standard Resuscitation Fluids
Y. John Wang, Ph.D.
Synzyme Tech., Inc., Irvine, Calif.
Polynitroxyl-Albumin for Treatment of Reperfusion Injury
Kenneth Mattox, M.D.
Baylor University
Complications of Fluid Resuscitation
10:05
BREAK
10:20
PANEL 6: NOVEL THERAPIES FOR HEMORRHAGE
(15-minute presentations, each followed by 5 minutes of discussion)
Alan S. Rudolph, Ph.D.
Naval Research Laboratory
Oxygen-Carrying Resuscitation Fluids
OCR for page 176
Carleton J. C. Hsia, Ph.D.
Synzyme Tech., Inc., Irvine, Calif.
Reperfusion Injury in Hemorrhage as a Therapeutic Target
Paul Segall, Ph.D.
BioTime, Inc., Berkeley, Calif.
Using Hextend to Treat Hemorrhagic Shock
Bo E. Hedlund, Ph.D.
Biomedical Frontiers, Inc.
Beyond Volume Expansion: Treatment of Reperfusion Injury by Iron Chelation
John L. Gainer, Ph.D.
University of Virginia
Fluid Additive for Promoting Oxygen Consumption
T.M.S. Chang, M.D., Ph.D., M.R.C.P.
McGill University, Montreal, Canada
Polyhemoglobin-Superoxide Dismutase-Catalase: A New Blood Substitute
12:20 p.m.
LUNCH
1:20
AGENDA ACCOMODATION II
(15-minute presentations, each followed by 5 minutes of discussion)
William P. Wiesmann, M.D., Colonel, USA, Retired
Biostar
Occult Hemorrhage Detection on the Battlefield by Means of Novel Microwave Sensors/Detectors (from Panel 2)
John J. Lemasters, M.D., Ph.D.
University of North Carolina
Cellular Responses to Hypoxia (from Panel 4)
2:00
PANEL 7: NOVEL THERAPIES FOR HEMORRHAGE
(15-minute presentations, each followed by 5 minutes of discussion)
Andrew Salzman, M.D.
Cincinnati Children's Hospital
Treatment of Hemorrhage with MEG
OCR for page 177
Alan Kim Johnson, Ph.D.
University of Iowa
Treatment of Hemorrhage with Melanocyte-Stimulating Hormones
William R. Millington, Ph.D.
University of Missouri, Kansas City
Neurobiology of Hemorrhagic Shock
Florence M. Rollwagen, Ph.D.
Uniformed Services University of the Health Sciences
Oral Cytokines for Treatment of Hemorrhagic Shock
Radha K. Maheshwari, Ph.D.
Uniformed Services University of the Health Sciences
Picroliv: Beneficial Effects in Hypoxia/Ischemia
Barbara A. Araneo, Ph.D.
Pharmadigm Biosciences Inc., Salt Lake City, Utah
Intravenous DHEA in the Treatment of Burn Syndrome
4:20
PANEL 8: HYPOTHERMIA IN TREATMENT OF HEMORRHAGE
(15-minute presentations, each followed by 5 minutes of discussion)
Samuel Tisherman, M.D.
University of Pittsburgh
Hypotensive Hypothermic Fluid Resuscitation During Uncontrolled Hemorrhagic Shock in Rats and Hypothermic Strategies for Suspended Animation with Delayed Resuscitation in Dogs
Peter Safar, M.D.
University of Pittsburgh
Pharmacologic-Hypothermic Suspended Animation
5:00
GENERAL DISCUSSION AND CLOSING REMARKS
David E. Longnecker, M.D.
Committee Chair
5:30
ADJOURN
OCR for page 178
This page in the original is blank.
Representative terms from entire chapter:
fluid resuscitation